Frontier Medicines: Funding, Investors & Team (Sep 2026)
Frontier Medicines is a biopharmaceutical company utilizing a chemoproteomics platform to expedite the creation of medications. This platform incorporates sophisticated computational methods and machine learning to identify and target novel binding sites on proteins, enabling easier development of small-molecule drugs.
Frontier Medicines has raised $189M across 3 funding rounds on record, the most recent a Series C of $20.0M announced in Jun 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Frontier Medicines Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Frontier Medicines Funding Rounds
Frontier Medicines raised $88.5M in a Series B announced in Jul 2021.
2.6 years later, a Series C of $80.0M was announced in Feb 2024.
4 months later, a Series C of $20.0M was announced in Jun 2024.
Frontier Medicines Founders and Leadership Team
Contact details for the Frontier Medicines team: 1 of 1 has an email address on file.
Start 14-day free trial →Frontier Medicines Funding Compared to Other Biotechnology Startups
Frontier Medicines' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Frontier Medicines in Biotechnology and San Francisco
Companies Similar to Frontier Medicines
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Frontier Medicines Funding FAQs
What does Frontier Medicines do?
Frontier Medicines is a biopharmaceutical company utilizing a chemoproteomics platform to expedite the creation of medications. This platform incorporates sophisticated computational methods and machine learning to identify and target novel binding sites on proteins, enabling easier development of small-molecule drugs.
How much funding has Frontier Medicines raised?
Frontier Medicines has raised $189M across 3 rounds on record. The most recent is a Series C of $20.0M announced in Jun 2024.
When did Frontier Medicines last raise funding?
Frontier Medicines' most recent funding round on record is a Series C of $20.0M, announced in Jun 2024.
Who founded Frontier Medicines?
FundedIQ lists Chris Varma (Founder) at Frontier Medicines.
Where is Frontier Medicines headquartered?
Frontier Medicines is based in San Francisco, California, United States.
How many employees does Frontier Medicines have?
Frontier Medicines is in the 101-250 employee band.
How does Frontier Medicines' funding compare to other Biotechnology startups?
Frontier Medicines' latest round of $20.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Frontier Medicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Frontier Medicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.